🔬 Pharmidex: Scientific Excellence Meets Client-Centric Delivery
August 4, 2025
At
Pharmidex, we go beyond exceptional science we deliver an experience built on trust, flexibility and deep collaboration.
📍
Scientist-Led from Start to Finish
Your journey begins and ends with scientists, not sales teams. Our BD and Ops leads bring real scientific expertise to every conversation, ensuring smart, tailored study design and seamless execution.
🤝
Connected Teams, Coordinated Delivery
From DMPK and bioanalysis to in vivo pharmacology, our integrated teams ensure smooth handoffs, eliminating delays and duplication.
🧪
Agile, High-Quality Science
We adapt to evolving study needs across CNS, oncology, respiratory, autoimmune and rare diseases without compromising on quality. GLP and non-GLP studies are delivered on time, with transparency.
🧭
We’re Not Just a CRO, We’re Your Partner
We offer guidance on model selection, regulatory strategy, data interpretation, and more. Your success is our mission.
Let’s partner on your next breakthrough.
📧 Contact us today.
We are pleased to share that Ian Knowles and Martin Barrett will attend Pharmacology 2025, organized by The British Pharmacological Society (BPS), at the ICC Belfast from 16–18 December 2025. They will host a Pharmidex exhibition stand, showcasing our key services and their importance in drug discovery and development. Ian and Martin will be delighted to meet attendees, exchange ideas, and explore new collaboration opportunities. Come and say hello!
Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) and Janette Dalay Robertson will attend the “Recent Clinical Candidates and SMR Award Meeting” this Thursday, 4 December 2025. If you’re attending, we’d be happy to connect!
